The HEAL Initiative is offering this R01-level grant to foster research into harm reduction policies, practices, and delivery methods. This grant aims to enhance our understanding of the effectiveness, implementation, and overall impact of harm reduction strategies, particularly in addressing the ongoing opioid crisis and substance use disorder more broadly. Funding supports projects focused on developing and testing novel harm reduction approaches, investigating effective implementation techniques for both new and existing strategies, and expanding the settings and models through which these vital services are delivered. Additionally, the initiative encourages research that examines the real-world impact of new harm reduction policies enacted at state and local levels, ultimately contributing to more effective interventions for affected populations.
Opportunity ID: 337172
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-22-046 |
Funding Opportunity Title: | HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 29, 2021 |
Last Updated Date: | Dec 29, 2021 |
Original Closing Date for Applications: | Mar 10, 2022 |
Current Closing Date for Applications: | Mar 10, 2022 |
Archive Date: | Apr 15, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Independent school districts Small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Special district governments City or township governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This funding opportunity announcement seeks R01-level projects aimed at increasing our understanding of the effectiveness, implementation, and impact of existing and new harm reduction practices to address the ongoing opioid crisis and substance use disorder more broadly. Projects may include: (1) developing and testing new harm reduction strategies; (2) examining how to effectively implement new and existing harm reduction strategies; (3) expanding the settings and delivery models through which harm reduction strategies are deployed; and (4) examining the impact of new harm reduction policies implemented at state and local levels. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-046.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 337172 Full Announcement-RFA-DA-22-046 -> RFA-DA-22-046-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271136 | Feb 10, 2022 | Mar 10, 2022 | View |
Package 1
Mandatory forms
337172 RR_SF424_5_0-5.0.pdf
337172 PHS398_CoverPageSupplement_5_0-5.0.pdf
337172 RR_OtherProjectInfo_1_4-1.4.pdf
337172 PerformanceSite_4_0-4.0.pdf
337172 RR_KeyPersonExpanded_4_0-4.0.pdf
337172 PHS398_ResearchPlan_4_0-4.0.pdf
337172 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337172 RR_Budget_3_0-3.0.pdf
337172 RR_SubawardBudget30_3_0-3.0.pdf
337172 PHS398_ModularBudget_1_2-1.2.pdf
337172 PHS_AssignmentRequestForm_3_0-3.0.pdf